Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis

BACKGROUND: The lipoprotein(a) pathway is a causal factor in coronary heart disease. We used a genetic approach to distinguish the relevance of two distinct components of this pathway, apolipoprotein(a) isoform size and circulating lipoprotein(a) concentration, to coronary heart disease. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleheen, Danish, Haycock, Philip C, Zhao, Wei, Rasheed, Asif, Taleb, Adam, Imran, Atif, Abbas, Shahid, Majeed, Faisal, Akhtar, Saba, Qamar, Nadeem, Zaman, Khan Shah, Yaqoob, Zia, Saghir, Tahir, Rizvi, Syed Nadeem Hasan, Memon, Anis, Mallick, Nadeem Hayyat, Ishaq, Mohammad, Rasheed, Syed Zahed, Memon, Fazal-ur-Rehman, Mahmood, Khalid, Ahmed, Naveeduddin, Frossard, Philippe, Tsimikas, Sotirios, Witztum, Joseph L, Marcovina, Santica, Sandhu, Manjinder, Rader, Daniel J, Danesh, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Lancet, Diabetes & Endocrinology 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483508/
https://www.ncbi.nlm.nih.gov/pubmed/28408323
http://dx.doi.org/10.1016/S2213-8587(17)30088-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483508/
https://www.ncbi.nlm.nih.gov/pubmed/28408323
http://dx.doi.org/10.1016/S2213-8587(17)30088-8

Ejemplares similares